Evidence map›Paper›PMID 34985430›Full record

ArticleJournal of synchrotron radiation2022

Evaluation of silicon strip detectors in transmission mode for online beam monitoring in microbeam radiation therapy at the Australian Synchrotron.

Jeremy Davis, Andrew Dipuglia, Matthew Cameron, Jason Paino, Ashley Cullen, Susanna Guatelli, Marco Petasecca, Anatoly Rosenfeld, Michael Lerch

Abstract read
In one paragraph

Article in Journal of synchrotron radiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jeremy DavisCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Andrew DipugliaCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Matthew CameronCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Jason PainoCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.ORCID 0000-0002-3648-7880
Ashley CullenCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Susanna GuatelliCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Marco PetaseccaCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Anatoly RosenfeldCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.ORCID 0000-0001-5116-6308
Michael LerchCentre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.

Funding

Australian Synchrotron 12533Australian Synchrotron 14657Australian Synchrotron 16221National Health and Medical Research Council APP1084994National Health and Medical Research Council APP1093256
6 · The paper itself

Abstract

Successful transition of synchrotron-based microbeam radiation therapy (MRT) from pre-clinical animal studies to human trials is dependent upon ensuring that there are sufficient and adequate measures in place for quality assurance purposes. Transmission detectors provide researchers and clinicians with a real-time quality assurance and beam-monitoring instrument to ensure safe and accurate dose delivery. In this work, the effect of transmission detectors of different thicknesses (10 and 375 µm) upon the photon energy spectra and dose deposition of spatially fractionated synchrotron radiation is quantified experimentally and by means of a dedicated Geant4 simulation study. The simulation and experimental results confirm that the presence of the 375 µm thick transmission detector results in an approximately 1-6% decrease in broad-beam and microbeam peak dose. The capability to account for the reduction in dose and change to the peak-to-valley dose ratio justifies the use of transmission detectors as thick as 375 µm in MRT provided that treatment planning systems are able to account for their presence. The simulation and experimental results confirm that the presence of the 10 µm thick transmission detector shows a negligible impact (<0.5%) on the photon energy spectra, dose delivery and microbeam structure for both broad-beam and microbeam cases. Whilst the use of 375 µm thick detectors would certainly be appropriate, based upon the idea of best practice the authors recommend that 10 µm thick transmission detectors of this sort be utilized as a real-time quality assurance and beam-monitoring tool during MRT.

Indexed as

SiliconSynchrotronsAnimalsAustraliaHumansMonte Carlo MethodRadiotherapy DosageSiliconbeam monitoringmicrobeam radiation therapyreal-time dosimetrytransmission detectors

Identifiers

PMID34985430
PMCPMC8733993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.